In stock
Bestseller
BPC-157 Online
BPC-157 is a synthetic peptide, based on a protective protein found in human gastric juice, studied in preclinical research for tissue repair and gut-lining support. Explore clinician-guided BPC-157 therapy with transparent pricing, online provider review, and licensed pharmacy fulfillment.
BPC-157 is a peptide studied in preclinical research for tissue repair and gut-lining support.
Home injection kit included with every plan.
Free shipping in discreet packaging.
What is BPC-157 and why does it matter?
BPC-157 is a synthetic 15-amino-acid peptide based on a partial sequence of a protective protein in human gastric juice. It has been studied mainly in animal research for tendon, ligament, and gut-lining repair — which is why it became popular in the recovery space. It is not an FDA-approved drug.
What are the potential benefits of BPC-157?
Preclinical studies — mostly in rodents — report faster soft-tissue healing and protection of the stomach and intestinal lining. Human evidence is minimal, so any benefits should be considered unproven; a licensed provider can help set realistic expectations.
How is BPC-157 different from TB-500?
Both are recovery peptides studied preclinically, but BPC-157 derives from a gastric protective protein with findings in tendon and gut repair, while TB-500 is based on thymosin beta-4, a protein involved in cell migration and wound healing.
Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. A licensed provider determines whether a compounded medication is appropriate based on an individual patient’s medical needs.
Sermorelin is not HGH — it is a peptide that signals the body’s own pituitary gland. Sermorelin is not a substitute for medical care, healthy sleep, nutrition, or exercise, and is not appropriate for everyone (including pregnancy, breastfeeding, or active malignancy — see eligibility below). Treatment is available only after review by a licensed healthcare provider. Individual results vary. Compounded medications are not FDA-approved; FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.
Provider-reviewed
Licensed pharmacy fulfillment
Free discreet shipping
How Clinician-Guided BPC-157 Therapy Works
Recovery is central to feeling and performing your best — and it becomes harder with age, training load, and gut stress. BPC-157 is a peptide studied in preclinical research for its effects on tendon, ligament, and muscle repair and on protecting the gut lining. Through DripVitals, a licensed provider reviews your health history and determines whether clinician-guided BPC-157 therapy is appropriate for you, with honest expectations about what the research does and does not show.
The basics
What Is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic peptide made of 15 amino acids, based on a partial sequence of a protective protein found in human gastric juice. When prescribed, it is prepared as a compounded medication and typically administered as a small subcutaneous injection, with dosing set by your clinician.
What BPC-157 is
BPC-157 replicates a fragment of the naturally occurring Body Protection Compound, which is thought to play a role in protecting and repairing the gastrointestinal lining. Researchers isolated this stable 15-amino-acid sequence because it retained biological activity in laboratory models.
How it has been studied
In preclinical models — mostly rodents — BPC-157 has been examined for accelerated healing of tendon, ligament, and muscle injuries, protection of the stomach and intestinal lining, and effects on blood-vessel signaling and nitric-oxide pathways involved in tissue repair (see references).
BPC-157 versus TB-500
BPC-157 and TB-500 are the two most discussed recovery peptides. They are different molecules with different mechanisms: BPC-157 relates to gut-derived tissue protection, while TB-500 is based on thymosin beta-4, an actin-binding protein involved in cell migration. A provider can discuss whether either fits your situation.
Why a provider consultation matters
Compounded BPC-157 dispensed through this program is not FDA-approved, and the FDA has raised safety concerns about BPC-157 in the compounding context; the FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. Robust human trials have not been completed. A licensed provider determines whether treatment is appropriate after reviewing your history, medications, and goals. You can start the online consultation here.
Why do people explore BPC-157 therapy?
Studied in preclinical research for tendon, ligament, and muscle recovery.
Studied in animal models for protecting and supporting the gut lining.
Clinician-guided dosing with licensed-pharmacy preparation and support.
Potential benefits are not guaranteed. Evidence for specific outcomes from compounded BPC-157 is limited and largely preclinical, and individual results vary. A licensed provider determines whether treatment is appropriate. See clinical references.
How to Start BPC-157 Injections Online
Every wellness journey is different, and so are our customized BPC-157 treatment plans.
STEP #1
Select your treatment
Choose a plan that fits your needs and complete a medical intake form for review by providers.
STEP #2
Provider evaluation
A licensed provider reviews your history to determine if BPC-157 therapy is right for you — all online.
STEP #3
Your medication, delivered
If approved, your BPC-157 ships in 3–5 days with discreet packaging, so you can start your journey.
What the research shows about BPC-157
BPC-157 has a large preclinical literature — mostly rodent studies — reporting accelerated soft-tissue healing and gut-lining protection, which is why it became one of the most discussed peptides in the recovery space (see references). The honest summary: human evidence is minimal, no large controlled trials have been completed, and promising animal data does not always translate to people. A licensed provider can help you weigh the research and decide whether treatment fits your goals and history.
- Based on a protective protein sequence from human gastric juice
- Studied preclinically in tendon, ligament, muscle, and gut-lining repair
- Typically self-administered as a small subcutaneous injection
- Prescription-only, with clinician-set dosing and follow-up
Safety
BPC-157 Safety, Side Effects, and Eligibility
Because controlled human trials are lacking, BPC-157’s side-effect profile is not well characterized. Reviewing the following with a licensed provider is an essential part of treatment.
Potential side effects
Reported effects in wellness use are generally mild and may include injection-site reactions (redness, soreness, swelling), nausea, dizziness, or fatigue. Because long-term human safety data does not exist, report any unusual or persistent symptoms to your care team, and seek prompt medical attention for severe reactions such as difficulty breathing or signs of an allergic reaction.
Who Should Not Use BPC-157?
BPC-157 is generally avoided during pregnancy or breastfeeding and in people with active cancer or a cancer history, because of its studied effects on blood-vessel growth. Competitive athletes should not use it: BPC-157 is prohibited by the World Anti-Doping Agency. Your provider reviews your history and will decline treatment when it is not safe or appropriate. Not everyone who applies will qualify.
Drug-interaction review
Share a complete list of your prescriptions, over-the-counter products, vitamins, and supplements during your consultation so your provider can check for potential interactions. Never start, stop, or change a medication without talking to a licensed provider.
When to contact a medical provider, and why results vary
Contact your provider if you experience side effects, have questions about dosing, or notice anything unexpected. Individual results vary, robust human evidence for BPC-157 is limited, and no specific outcome is guaranteed.
Compounded medications are not FDA-approved, and the FDA has raised safety concerns about BPC-157 in the compounding context. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. A licensed provider determines whether a compounded medication is appropriate for an individual patient.
Comparison
BPC-157 vs. TB-500
A common question is how BPC-157 compares with TB-500, the other widely discussed recovery peptide. Both require a provider’s guidance; the key difference is the biology each is based on.
| Feature | BPC-157 | TB-500 |
|---|---|---|
| Origin | Fragment of a gastric protective protein | Based on thymosin beta-4, an actin-binding protein |
| Research focus | Tendon, ligament, muscle, and gut-lining repair | Cell migration, dermal and corneal wound healing |
| Human evidence | Minimal; no completed controlled trials | Limited; early-phase trials in non-injected forms |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Best option | Depends on medical history and goals | Depends on medical history and goals |
Neither peptide is established as superior — and neither is FDA-approved. The right choice, if any, depends on your medical history, goals, and your provider’s recommendation. Learn more about TB-500.
Comparison
BPC-157 vs. Other Recovery Peptides
BPC-157 sits in a family of peptides explored for recovery and wellness. TB-500 is studied through cell-migration and wound-healing pathways, while sermorelin — a growth-hormone-releasing peptide with a longer clinical history — works on the pituitary’s GHRH receptor. Some protocols discuss combining peptides, but any combination decision belongs to a licensed clinician.
Which peptide, or combination, is appropriate depends entirely on your goals, health history, and a licensed provider’s assessment. The compounded peptides offered through this program are not FDA-approved for these uses and are dispensed only by prescription through licensed compounding pharmacies.
Why Choose a Clinician-Guided BPC-157 Treatment Plan?
- 1-on-1 guidance from US-based licensed health experts
- Structured dosing and regular check-ins with your care team
- No-cost consultations for continuous treatment optimization
- Fast, discreet delivery with 24/7 messaging support
- Plans designed to stay affordable across commitment lengths
Program
What Is Included in the DripVitals BPC-157 Program?
A DripVitals BPC-157 program is a clinician-guided subscription that bundles your care and medication. Depending on what your provider prescribes, it typically includes:
- Online medical consultation and licensed-provider review
- Your prescribed BPC-157 from a licensed compounding pharmacy
- Home injection supplies, where applicable
- Free, discreet shipping
- Ongoing messaging access to your care team
- Follow-up check-ins with dose adjustments when clinically appropriate
- A subscription you can cancel at any time
BPC-157 Injection Cost and Pricing
Pricing depends on the plan you choose and what your provider prescribes. There are no hidden fees, and your dashboard shows exactly what you pay and when.
| Plan | Price | Billing |
|---|---|---|
| Month-to-month | $219/mo | $219 billed monthly |
| 3-Month plan | $199/mo* | $597 billed every 3 months |
| 6-Month plan | $189/mo* | $1,134 billed every 6 months |
*Monthly rates reflect plan length: $199/mo billed $597 every 3 months, $189/mo billed $1,134 every 6 months. Actual price depends on the plan and treatment prescribed. Plans are offered as a subscription that can be canceled at any time.
Choose Your BPC-157 Treatment Plan
Select the plan that fits your goals and complete a secure online intake. A licensed provider reviews your health history and prescribes only when appropriate — you are not charged for medication unless prescribed, and you can cancel future renewals anytime.
- Online medical evaluation & licensed-provider review
- Prescribed medication from a licensed U.S. pharmacy, if approved
- Home injection kit & supplies included
- Free, discreet shipping & ongoing clinical support
Compounded medications are not FDA-approved. Treatment requires a prescription and is available only where our clinicians are licensed. See Important Safety Information.
Trust
Medically Reviewed
Medically reviewed by
ABAARM · FAAMM · DABOM
Hormone OptimizationObesity & Metabolic MedicineLongevity-Focused CareFunctional Medicine
Last medically reviewed:
This page was reviewed for medical accuracy. Treatment decisions are made by a licensed provider after reviewing each patient’s medical history.
Education & certifications
- American Board of Anti-Aging and Regenerative Medicine (ABAARM)
- Anti-Aging Metabolic Medicine, American Academy of Anti-Aging Medicine
- American Board of Obesity Medicine (DABOM)
- American Board of Internal Medicine
- The Institute for Functional Medicine
- Bioidentical Hormone Replacement Therapy certified
- Peptide Certification / Member, International Peptide Society
- Integrative Gastroenterology, Endocrinology, Cardiology & Neurology Certification, The George Washington University School of Medicine and Health Sciences
- Member, The American Academy of Anti-Aging Medicine (A4M)
- Member, American College of Physicians
Evidence
Clinical References and Further Reading
These sources discuss BPC-157 and related preclinical research. They describe general research — largely in animal models — and do not establish specific clinical outcomes from this program.
- Sikiric P, et al. Stable gastric pentadecapeptide BPC 157 — reviews of preclinical pharmacology. Current Pharmaceutical Design.
- Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing. Journal of Applied Physiology.
- Gwyer D, et al. Gastric pentadecapeptide BPC 157 and its role in musculoskeletal soft tissue healing: a systematic review of preclinical evidence. Cell and Tissue Research.
- U.S. FDA — communications regarding certain bulk drug substances nominated for use in compounding, including identified safety concerns for BPC-157.
- World Anti-Doping Agency — Prohibited List, non-approved substances (S0).
You may also like
BPC-157: Frequently Asked Questions
Clear, medically reviewed answers about BPC-157 — the research status, safety, administration, and how the online program works.
What is BPC-157?
BPC-157 is a synthetic 15-amino-acid peptide based on a partial sequence of a protective protein found in human gastric juice. It has been studied mainly in animal research for tissue repair and gut-lining protection, and it is not an FDA-approved drug.
What is BPC-157 used for?
In wellness settings, clinicians prescribe compounded BPC-157 for patients interested in recovery and gut-health support based on preclinical research. Robust human trials have not been completed, so it is used under clinician judgment with realistic expectations — not as a proven treatment for any condition.
Is BPC-157 FDA-approved?
No. BPC-157 is not FDA-approved for any use, and compounded preparations are not FDA-approved products. The FDA has also raised safety concerns about BPC-157 in the compounding context — something your provider will discuss before any prescription.
What does the research actually show?
Animal studies — mostly in rodents — report faster tendon, ligament, and muscle healing and protection of the stomach and intestinal lining. Human evidence is minimal: no large controlled trials establish efficacy or long-term safety, and promising animal data does not always translate to people.
What are the potential side effects of BPC-157?
Reported effects in wellness use are generally mild — injection-site redness or soreness, occasional nausea, dizziness, or fatigue — but because controlled human trials are lacking, the full side-effect profile is not well characterized. Report anything concerning to your care team promptly.
Who should not use BPC-157?
It is generally avoided during pregnancy or breastfeeding and in people with active cancer or a cancer history, and a provider may decline it based on your medications or health history. Tested athletes should not use it: BPC-157 is prohibited under the WADA code.
How is BPC-157 administered?
When prescribed, BPC-157 is typically self-administered as a small subcutaneous injection into the fatty tissue of the abdomen or thigh, using the supplies included with your program. Your provider sets the dose and schedule, and your care team reviews proper technique.
Is BPC-157 legal?
Obtaining BPC-157 through a licensed provider's prescription filled by a licensed compounding pharmacy is the legitimate pathway where available. Buying it from 'research chemical' websites without a prescription means unverified purity and no medical oversight — we recommend against it.
How is BPC-157 different from TB-500?
Both are recovery peptides studied preclinically, but through different mechanisms: BPC-157 derives from a gastric protective protein with findings in tendon and gut-lining repair, while TB-500 is based on thymosin beta-4, involved in cell migration and wound healing.
What is included in the DripVitals program?
Your plan includes the online medical consultation and provider review, your prescribed medication if approved, injection supplies, free discreet shipping, and ongoing clinical support with dose guidance and follow-ups. You are not charged for medication unless a licensed provider prescribes it.
Is a consultation required?
Yes. Treatment requires a prescription, so a licensed provider must review your health information first — and can decline treatment when it is not appropriate. Not everyone who applies will qualify.
How is pricing determined?
Pricing depends on the plan you choose: $219/month billed monthly, $199/month on the 3-month plan (billed $597), and $189/month on the 6-month plan (billed $1,134). Longer commitments lower the effective monthly price, you see your exact cost before you confirm, and you can cancel future renewals at any time.
Disclaimer
Only available if prescribed after an online consultation with a healthcare provider. Benefits outlined are based on third-party studies. Plans are offered as a subscription service which can be canceled at any time. Actual product packaging may appear differently than shown. Physicians may prescribe compounded medications as needed to meet patient requirements. The FDA does not review or approve any compounded medications for safety or effectiveness. The statements on this page have not been evaluated by the FDA. Results may vary. If you notice any side effects while using this treatment, contact your healthcare provider immediately. BPC-157 is not FDA-approved for any use; statements on this page describe areas studied in preclinical and early research, and robust human clinical evidence is limited. The FDA has identified safety concerns with BPC-157 for use in compounding, and BPC-157 is prohibited for tested athletes under the World Anti-Doping Agency code.